Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns

Archives of Virology

Volumn 152, Issue 6, 2007, Pages 1159-1173

  Pan, X B ^a   Wei, L ^a   Chen, H S ^a   Liu, F ^a   Gao, Y ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PRIMER DNA; VIRUS DNA;

ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DNA MICROARRAY; DNA REPLICATION; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; HUMAN; LIVER CELL; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; DNA PRIMERS; DNA REPLICATION; DNA, VIRAL; GENE EXPRESSION PROFILING; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VIRULENCE; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 34249091756     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0927-4     Document Type: Article

References (58)

1. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR (1988) Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66: 1-10
2. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804
3. Chang CM, Jeng KS, Hu CP, Lo SJ, Su TS, Ting LP, Chou CK, Hang SH, Praff E, Salfeld J (1987) Production of hepatitis B virus in vitro by transient expression of cloned HBV-DNA in a hepatoma cell line. EMBO J 6: 675-680
4. Choi CY, Choi BH, Park GT, Rho HM (1997) Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimers. J Biol Chem 272: 16934-16939
5. Choi BH, Park GT, Rho HM (1999) Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem 274: 2858-2865
6. Davis RJ (1995) Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467
7. Eura M, Chikamatsu K, Ogi K, Nakano K, Masuyama K, Ishikawa T (1995) Expression of genes MAGE-1, -2, and -3 by human maxillary carcinoma cells. Anticancer Res 15: 55-59
8. Fellig Y, Almogy G, Galun E, Ketzinel-Gilad M (2004) A hepatocellular carcinoma cell line producing mature hepatitis B viral particles. Biochem Biophys Res Commun 321: 269-274
9. Feng DY, Sun Y, Cheng RX, Ouyang XM, Zheng H (2005) Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol 11: 2157-2161
10. Gilbert S, Galarneau L, Lamontagne A, Roy S, Belanger L (2000) The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J Virol 74: 5032-5039
11. Gripon P, Diot C, Corlu A, Guguen-Guillouzo C (1989) Regulation by dimethylsulfoxide, insulin, and corticosteroids of hepatitis B virus replication in a transfected human hepatoma cell line. J Med Virol 28: 193-199
12. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, Guguen-Guillouzo C (1988) Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulphoxide. J Virol 62: 4136-4143
13. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99: 15655-15660
14. Gunther S, Sommer G, Von Breunig F, Iwanska A, Kalinina T, Sterneck M, Will H (1998) Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 36: 531-538
15. Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F, Li Z, Wang Y, Ma S, Tao J, Wang W, Zhou Y, Yang W, Cheng J (2005) Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 79: 14392-14403
16. He QQ, Cheng RX, Sun Y, Feng DY, Chen ZC, Zheng H (2003) Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol 9: 474-478
17. Horowitz JM (1993) Regulation of transcription by the retinoblastoma protein, Genes. Chromosomes Cancer 6: 124-131
18. Huang R, Xing Z, Luan Z, Wu T, Wu X, Hu G (2003) A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res 63: 3775-3782
19. Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, Mita EA, Kasahara, Sasaki Y, Hori M, Hayashi N (2000) Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 74: 1241-1251
20. Knowles BB, Howe CC, Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 497-499
21. Kramvis A, Kew MC (1999) The core promoter of hepatitis B virus. J Viral Hepat 6: 415-427
22. Lai CK, Ting LP (1999) Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. J Virol 73: 3197-3209
23. Lichy JH, Majidi M, Elbaum JT, Sai MM(1996) Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression. Nucleic Acids Res 24: 4700-4708
24. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808
25. Liou J, Jeng K, Lin C, Chang C (1998) A novel regulator inhibits HBV gene expression. J Biomed Sci 5: 343-354
26. Lu CC, Yen TS (1996) Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. Virology 225: 387-394
27. Lu X, Block T (2004) Study of the early steps of the Hepatitis B Virus life cycle. Int J Med Sci 1: 21-33
28. Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252: 842-844
29. Melegari M, Scaglioni PP, Wands JR (1998) Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 72: 1737-1743
30. Moolla N, Kew M, Arbuthnot P (2002) Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9: 323-331
31. Moriki T, Maruyama H, Maruyama IN (2001) Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 311: 1011-1026
32. Nimmrich I, Erdmann S, Melchers U, Chtarbova S, Finke U, Hentsch S, Hoffmann I, Oertel M, Hoffmann W, Muller O (2001) The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cells. Cancer Lett 165: 71-79
33. Ohno H, Kaneko S, Kobayashi K, Murakami S (1997) Human hepatitis B virus enhancer 1 is responsive to human interleukin-6. J Med Virol 52: 413-418
34. Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, Yoffe B (1996) Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 110: 1519-1528
35. Paran N, Geiger B, Shaul Y (2001) HBV infection of cell culture: evidence for multivalent and cooperative attachment. EMBO J 20: 4443-4453
36. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45
37. zu Putlitz J, Roberts EA, Wieland S, Kono Y, Blum HE (1997) Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver. Virus Res 52: 177-182
38. Raney AK, Johnson JL, Palmer CN, McLachlan A (1997) Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 71: 1058-1071
39. Raney AK, Le HB, McLachlan A (1992) Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 66: 6912-6921
40. Raney AK, McLachlan A (1997) Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site. J Gen Virol 78: 3029-3038
41. Robinson WS (1977) The genome of hepatitis B virus. Annu Rev Microbiol 31: 357-377
42. Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM (2006) Crystal structure of human cytochrome P450 2D6. J Biol Chem 281: 7614-7622
43. Rumin S, Gripon P, Le Seyec J, Corral-Debrinski M, Guguen-Guillouzo C (1996) Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro. J Viral Hepat 3: 227-238
44. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68
45. Sells MA, Zelent AZ, Shvartsman M, Acs G (1988) Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62: 2836-2844
46. Shaul Y, Ben-Levy R, De-Medina T (1986) High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. EMBO J 8: 1967-1971
47. Sureau C, Romet-Lemonne JL, Mullins JI, Essex M (1986) Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47: 37-47
48. Tang H, McLachlan A (2001) Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA 98: 1841-1846
49. Tichopad A, Dilger M, Schwarz G, Pfaffl MW (2003) Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res 3: e122
50. Tuttleman JS, Pourcel C, Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47: 451-460
51. Uchida D, Omotehara F, Nakashiro K, Tateishi Y, Hino S, Begum NM, Fujimori T, Kawamata H (2003) Posttranscriptional regulation of TSC-22 (TGF-beta-stimulated clone-22) gene by TGF-beta 1. Biochem Biophys Res Commun 305: 846-854
52. Wang Y, Wei L, Jiang D, Cong X, Fei R, Xiao J, Wang Y (2005) In vitro resistance to interferon of hepatitis B virus with precore mutation. World J Gastroenterol 11: 649-655
53. Waris G, Siddiqui A (2002) Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol 76: 2721-2729
54. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15
55. Yeh CT, Chiu HT, Chu CM, Liaw YF (1998) G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. J Med Virol 5542-5550
56. Yeh CT, Lai HY, Chu SP, Tseng IC (2004) Anti-sense expression of a metallopeptidase gene enhances nuclear entry of HBV-DNA. Biochem Biophys Res Commun 323: 32-37
57. Yu X, Mertz JE (1997) Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71: 9366-9374
58. Yu X, Mertz JE (2001) Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J Virol 75: 11354-11364